SCHEMBL7001034

SCHEMBL7001034

CCC(O)c1ccc2c(c1)N=C(N)C(C)O2

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.33
AOC3 Q16853 1/20 0.33
NFKB1 P19838 1/20 0.32
BLM P54132 3/20 0.31
PMP22 Q01453 1/20 0.31
ESR1 P03372 1/20 0.31
ESR2 Q92731 1/20 0.31
HIF1A Q16665 1/20 0.30
EPAS1 Q99814 1/20 0.30
MAPT P10636 2/20 0.30
HPGD P15428 2/20 0.30
APEX1 P27695 2/20 0.30
RECQL P46063 2/20 0.30
TDP1 Q9NUW8 2/20 0.30
MEN1 O00255 1/20 0.30
ADRB2 P07550 1/20 0.30
ADRB1 P08588 1/20 0.30
ADRA2A P08913 1/20 0.30
ADORA3 P0DMS8 1/20 0.30
ADRB3 P13945 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6996663 0.85 SLC6A4 (0.34)
SCHEMBL7985549 0.72 MAPT (0.43) ESR1ESR2MAPTTDP1MEN1
SCHEMBL6996400 0.72 PIKFYVE (0.32) ESR1ESR2
Hydrochloric Acid SCHEMBL6991858 0.71 CYP3A4 (0.33) CYP3A4
SCHEMBL6611984 0.69 PARP1 (0.45) MEN1KMT2AKDM4E
SCHEMBL7708028 0.69 NOS3 (0.43) PTGS2MAPK1
SCHEMBL6994127 0.68 PARP1 (0.50)
SCHEMBL7985616 0.67 MAPT (0.47) NFKB1ESR1ESR2MAPTMEN1
SCHEMBL5670575 0.66 ESR1 (0.35) ESR1ESR2
Hydrochloric Acid SCHEMBL7711450 0.66 PARP1 (0.42) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015437-B1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AG (DE) 2003-12-03 EP disclosed
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed